These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 110860

  • 1. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
    Mojamdar M, Imokawa G, Mishima Y.
    J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
    [No Abstract] [Full Text] [Related]

  • 2. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
    Tomita Y, Moro S, Seiji M.
    J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
    [No Abstract] [Full Text] [Related]

  • 3. [Active tyrosinase site in melanin synthesizing cells; biochemical study of GERL (author's transl)].
    Imokawa G, Mishima Y.
    Nihon Hifuka Gakkai Zasshi; 1978 Mar; 88(4):275-87. PubMed ID: 97423
    [No Abstract] [Full Text] [Related]

  • 4. Isolation and biochemical characterization of tyrosinase-rich GERL and coated vesicle in melanin synthesizing cells.
    Imokawa G, Mishima Y.
    Br J Dermatol; 1981 Feb; 104(2):169-78. PubMed ID: 6783060
    [Abstract] [Full Text] [Related]

  • 5. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
    Imokawa G, Mishima Y.
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
    [No Abstract] [Full Text] [Related]

  • 6. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase.
    Iwata K, Takeuchi T.
    J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pathology and ultrastructural characteristics of a hypomelanotic variant of transplantable hamster melanoma with elevated tyrosinase activity.
    Bomirski A, Wrzołkowa T, Arendarczyk M, Bomirska M, Kuklinska E, Słominski A, Moellmann G.
    J Invest Dermatol; 1987 Nov; 89(5):469-73. PubMed ID: 3117904
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Purification and properties of tyrosinase isoenzymes from hamster melanoma.
    Pomerantz SH, Li JP.
    Yale J Biol Med; 1973 Dec; 46(5):541-52. PubMed ID: 4205121
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunoelectron microscopic demonstration of human melanosome associated antigens (HMSA) on melanoma cells: comparison with tyrosinase distribution.
    Akutsu Y, Jimbow K.
    J Invest Dermatol; 1988 Feb; 90(2):179-84. PubMed ID: 3123559
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of a Golgi-rich fraction from the Harding-Passey mouse melanoma.
    Seiji M, Moro S, Tomita Y.
    Tohoku J Exp Med; 1978 Sep; 126(1):63-70. PubMed ID: 100898
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.